Literature DB >> 30020833

Integrated communications between cyclooxygenase-2 and Alzheimer's disease.

Pei-Pei Guan1, Pu Wang1.   

Abstract

Elevated levels of cyclooxygenase-2 (COX-2) and prostaglandins (PGs) are involved in the pathogenesis of Alzheimer's disease (AD), which is characterized by the accumulation of β-amyloid protein (Aβ) and tau hyperphosphorylation. However, the gaps in our knowledge of the roles of COX-2 and PGs in AD have not been filled. Here, we summarized the literature showing that COX-2 dysregulation obviously influences abnormal cleavage of β-amyloid precursor protein, aggregation and deposition of Aβ in β-amyloid plaques and the inclusion of phosphorylated tau in neurofibrillary tangles. Neuroinflammation, oxidative stress, synaptic plasticity, neurotoxicity, autophagy, and apoptosis have been assessed to elucidate the mechanisms of COX-2 regulation of AD. Notably, an imbalance of these factors ultimately produces cognitive decline. The current review substantiates our understanding of the mechanisms of COX-2-induced AD and establishes foundations for the design of feasible therapeutic strategies to treat AD.-Guan, P.-P., Wang, P. Integrated communications between cyclooxygenase-2 and Alzheimer's disease.

Entities:  

Keywords:  apoptosis; autophagy; neuroinflammation; prostaglandins; synaptic plasticity

Mesh:

Substances:

Year:  2018        PMID: 30020833     DOI: 10.1096/fj.201800355RRRR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

1.  Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer's disease.

Authors:  Pei-Pei Guan; Xin Yu; Yan-Hui Zou; Pu Wang
Journal:  Cell Mol Immunol       Date:  2019-09-24       Impact factor: 11.530

2.  Prostaglandin A1 Decreases the Phosphorylation of Tau by Activating Protein Phosphatase 2A via a Michael Addition Mechanism at Cysteine 377.

Authors:  Guo-Biao Xu; Pei-Pei Guan; Pu Wang
Journal:  Mol Neurobiol       Date:  2020-10-23       Impact factor: 5.590

3.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

Review 4.  Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

Authors:  Awanish Mishra; Ritam Bandopadhyay; Prabhakar Kumar Singh; Pragya Shakti Mishra; Neha Sharma; Navneet Khurana
Journal:  Metab Brain Dis       Date:  2021-08-13       Impact factor: 3.584

5.  Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.

Authors:  Natalia A Stefanova; Nikita I Ershov; Nataliya G Kolosova
Journal:  Oxid Med Cell Longev       Date:  2019-07-15       Impact factor: 6.543

6.  Effect of Novel Pyrrolo[3,4-d]pyridazinone Derivatives on Lipopolysaccharide-Induced Neuroinflammation.

Authors:  Karolina Wakulik; Benita Wiatrak; Łukasz Szczukowski; Dorota Bodetko; Marta Szandruk-Bender; Agnieszka Dobosz; Piotr Świątek; Kazimierz Gąsiorowski
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

7.  Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations.

Authors:  Serena J Aleo; Valentina Del Dotto; Mario Fogazza; Alessandra Maresca; Tiziana Lodi; Paola Goffrini; Anna Ghelli; Michela Rugolo; Valerio Carelli; Enrico Baruffini; Claudia Zanna
Journal:  Hum Mol Genet       Date:  2021-01-21       Impact factor: 6.150

8.  Isoliquiritigenin Confers Neuroprotection and Alleviates Amyloid-β42-Induced Neuroinflammation in Microglia by Regulating the Nrf2/NF-κB Signaling.

Authors:  Yue Fu; Jianping Jia
Journal:  Front Neurosci       Date:  2021-02-11       Impact factor: 4.677

9.  A Network Pharmacological Approach to Investigate the Mechanism of Action of Active Ingredients of Epimedii Herba and Their Potential Targets in Treatment of Alzheimer's Disease.

Authors:  Yajuan Li; Qin Yang; Yang Yu
Journal:  Med Sci Monit       Date:  2020-09-27

10.  SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.

Authors:  Luigi Chiricosta; Agnese Gugliandolo; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2021-12-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.